Among the 31 enrolled patients, the following laboratory abnormalities were observed: anemia (35.5%), leukocytosis or lymphopenia (71.0%), thrombocytopenia (58.1%), CRP elevation (100.0%), elevated liver transaminases (83.9%), hypoalbuminemia (71.0%), coagulopathy (74.2%), and adherence to the 2016 MAS criteria (48.4%). This evidence concerns the gene CRP and Increased total leukocyte count.